"Usually we can work with them to bring them into compliance quickly, which ultimately is the goal," Dayman-Rutkus notes.
Aux États-Unis, les entreprises pharmaceutiques américaines ne doivent qu’enregistrer leurs activités auprès de la Food and Drug Administration et aucune inspection n’est requise.